TargaZyme

Growth Stage

The Next Frontier of Cancer Medicine

Analytics

Raised to Date: Raised: $33,785

Aggregate Commitments $

Platform

StartEngine

Start Date

05/24/2022

Close Date

08/18/2022

Min. Goal

$9,996

Max. Goal

$1,069,997

Min. Investment

$305

Security Type

Equity - Common

Funding Type

RegCF

Series

Series A

Price Per Share

$6.62

Pre-Money Valuation

$196,273,335

Rolling Commitments $

Status

Active

Reporting Date

06/25/2022

Days Remaining

54

% of Min. Goal

338%

% of Max. Goal

3%

Likelihood of Max
unlikely
Avg. Daily Raise

$1,056

Momentum
cold.svg
Create a free account today to gain access to KingsCrowd analytics.
Location

Carlsbad, California

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B

Margin

High

Capital Intensity

High

Business Type

Growth

TargaZyme, with a valuation of $196 million, is raising funds on StartEngine. The company is pioneering the development of cancer medicine that harnesses the power of the patient’s own immune system. The company is in the R&D stage and trying to eliminate chemotherapies, radiation, radical surgery, and other toxic drugs as treatments for cancer. The novel patented medicine of TargaZyme, TZ101, has shown to improve survival rates of cancer patients from 64% post-100 days of transplant to 78% post-100 days of transplant. Lynnet Koh founded TargaZyme in November 2005. The current crowdfunding campaign has a minimum target of $9,996.20 and a maximum target of $1,069,997.22. The campaign proceeds will be used to enable the delivery of cancer cures, further development of additional cures, and generate multiple revenue streams.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-2,416,916

$-2,483,254

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$111,900

$19,562

Accounts Receivable

$0

$0

Total Assets

$3,174,319

$3,455,588

Short-Term Debt

$7,524,097

$7,336,075

Long-Term Debt

$441,014

$203,700

Total Liabilities

$7,965,111

$7,539,775

Financials as of: 05/24/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
TargaZyme on StartEngine 2022
$
Platform: StartEngine
Security Type: Equity - Common
Valuation: $196,273,335

Follow company

Follow TargaZyme on StartEngine 2022
View on StartEngine
Bullish / Bearish
You're Bullish on TargaZyme on StartEngine 2022

Thank you for your vote on TargaZyme on StartEngine 2022

Bullish / Bearish
You're Bearish on TargaZyme on StartEngine 2022

Thank you for your vote on TargaZyme on StartEngine 2022